What is the ERA test?
The Endometrial Receptivity Analysis (ERA), developed and patented by Igenomix, is a test designed to evaluate endometrial receptivity.
This molecular diagnostic tool uses NGS to analyze the expression level of 248 genes related to the status of endometrial receptivity.
The ERA test has been shown to be highly sensitive and specific in the detection of genetic expression profiles associated with receptivity. It allows the personalized window of implantation to be detected before the patient starts using assisted reproduction techniques.
To do so, RNA obtained from an endometrial tissue sample is analyzed and then classified by our ERA predictor as receptive or non-receptive, depending on the expression profile of the RNA.
If the case where the endometrium is non-receptive, the test enables us to find a personalized window of implantation for each patient.